Dexcom | DXCM - 净收入



金融业
股票价格
USD
资产
USD 6.63B
现金及等价物
USD 1.12B
销售成本
USD 441.6M
流动资产
USD 4.33B
流动负债
USD 2.22B
债务
USD 1.24B
EBIT
USD 255.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.56
股本和储备
USD 2.96B
销售毛利
USD 750.3M
债务利息支出
USD 4.2M
利息收入
USD 23.5M
贷款资金
USD 1.3B
市值
USD 28.22B
净收入
USD 199.5M
营业费用
USD 936.6M
营业利润
USD 255.3M
普通股股本
USD 385.9M
PE价格收益
24.73
税前利润
USD 340.7M
销售收入
USD 1.19B
销售和管理费用
USD 349.7M
股票
USD 693.6M
贸易债权人
USD 1.94B
应收帐款人
USD 1.09B


净收入 更改 日
Abbott USD 1.08B 699M 2026-03
Align Technology USD 112.77M 22.99M 2026-03
AtriCure USD 108K 1.65M 2026-03
Avanos Medical USD 5.1M 6.4M 2026-03
Baxter International USD -15M 1.11B 2026-03
Becton, Dickinson and Co. USD -311M 693M 2026-03
Boston Scientific USD 1.34B 669M 2026-03
Cooper Companies USD 130.8M 46.2M 2025-12
Dexcom USD 199.5M 67.8M 2026-03
Edwards Lifesciences USD 380.7M 289.5M 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 91.1M 10.5M 2026-03
Integra LifeSciences USD -4.62M 2.91M 2026-03
J&J USD 5.24B 119M 2026-03
Masimo USD 57.1M 11.2M 2026-03
Medtronic USD 1.14B 231M 2025-12
Merit Medical Systems USD 41M 2.99M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Solventum Corp USD 13M 50M 2026-03
Stryker USD 745M 104M 2026-03
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -8.15M 706.18M 2026-03
West Pharmaceutical Services USD 138.8M 6.7M 2026-03
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03